Senestech Inc represents innovation, environmental responsibility, and a commitment to animal health and welfare. The company pioneers fertility control solutions for urban pest management, offering non-lethal and humane methods to control rodent populations. Senestech's flagship product, ContraPest®, is a unique contraceptive technology designed to reduce rodent populations in a safe and sustainable manner. By focusing on effective and ethical pest management, Senestech aims to create a world where humans and animals can coexist harmoniously. The company's dedication to sustainability and animal welfare underscores its core values, making Senestech a trusted leader in the industry.

Senestech Inc primarily operates in the United States.

Senestech Inc, a leading stock company, has achieved remarkable milestones throughout its journey. One significant accomplishment for Senestech Inc was the successful development and commercialization of ContraPest®, a patented rodent control product. This innovative solution revolutionizes traditional pest management methods, providing a humane, non-lethal approach to rodent population control. Additionally, Senestech Inc has formed crucial partnerships and collaborations, expanding its market reach and establishing a strong presence within the pest control industry. With its continuous commitment to advancing rodent control technologies, Senestech Inc has solidified its position as a pioneer in the field, offering effective and environmentally sustainable solutions.

Senestech Inc. is an innovative biotech company based in Flagstaff, Arizona. Founded in 2004, Senestech specializes in developing and commercializing reproductive control technologies for managing animal populations. The company's patented ContraPest® product offers a humane, non-lethal solution for controlling rat populations through fertility control. With a focus on environmentally friendly solutions, Senestech aims to provide effective rodent management tools that minimize harm to other species and the environment. Senestech's proven track record and commitment to sustainability have positioned the company as a leader in the pest control industry, offering a unique and effective approach to managing rodent populations.

The main competitors of Senestech Inc in the market are companies like Rentokil Initial PLC, Rollins Inc, Ecolab Inc, and Target Specialty Products.

Senestech Inc primarily operates in the field of animal fertility control.

Senestech Inc is a biotechnology company specializing in the development of innovative solutions for pest management. Their business model revolves around the commercialization of ContraPest, a groundbreaking rodent-control product. ContraPest is designed to target and reduce rodent populations in various settings, including urban and agricultural areas. By utilizing fertility control technology, Senestech provides a humane and efficient method for rodent management. The company's focus on sustainable pest control solutions has garnered significant attention and recognition in the industry. Senestech Inc aims to offer effective pest management strategies that ensure healthier and safer environments.

Det Senestech P/E-forhold er -0,04.

Senestech KUV er 0,10.

AlleAktien Kvalitetsscore for Senestech er 3/10.

Den forventede Senestech omsætning er 2,10 mio. USD.

Den forventede Senestech indtjening er -5,42 mio. USD.

Senestech Inc is an innovative company specializing in the development and marketing of eco-friendly pest control technologies. They offer a wide range of products and services to meet customer needs. One of their main areas of focus is the development of solutions for rodent control, with a product called ContraPest that inhibits the reproduction of rats and mice, reducing their population. Senestech also works on technologies for wildlife and unwanted species control, collaborating with industries such as agriculture. Their products and services are popular among veterinarians, farmers, and pet owners. In addition to product development, Senestech offers customized solutions and support services for pest control and animal management. The company prioritizes innovation and sustainability, investing in research and development for efficient, safe, and eco-friendly technologies. Overall, Senestech provides a unique and tailored business model to assist customers with pest control and animal management, focusing on sustainability and innovation.

Senestech udbetaler et udbytte på 0 USD fordelt over udbetalinger om året.

Udbyttet kan for nuværende ikke beregnes for Senestech, eller selskabet udbetaler ikke udbytte.

ISIN'en for Senestech er US81720R2085.

WKN for Senestech er A2PW5C.

Tickeren for Senestech er SNES.

I løbet af de sidste 12 måneder betalte Senestech en dividende på . Dette svarer til et dividendeudbytte på omkring . For de kommende 12 måneder vil Senestech sandsynligvis betale en dividende på 0 USD.

Udbytteafkastet for Senestech er i øjeblikket .

Senestech betaler kvartalsvis udbytte. Dette uddeles i månederne .

Senestech betalte udbytte hvert år i løbet af de sidste 0 år.

For de kommende 12 måneder forventes der dividender på 0 USD. Dette svarer til et dividendeafkast på 0 %.

Senestech bliver tildelt sektoren 'Sundhed'.

For at modtage det seneste udbytte på Senestech fra den 20.12.2024 på 0 USD, skulle du have haft aktien i din portefølje før ex-datoen den 20.12.2024.

Udbetalingen af det sidste udbytte blev foretaget den 20.12.2024.

I løbet af 2023 udbetalte Senestech 0 USD i form af dividender.

Udbytterne fra Senestech udbetales i USD.